Actos, which belongs to the same class of drugs as Avandia (Rosiglitazone), was approved in July 1999 by the U.S. Food and Drug Administration (FDA). The popular drug was developed for the treatment of type 2 diabetes. Patients taking Actos reported many side effects, including an increased risk of Actos bladder cancer. Takeda Pharmaceutical Co., has been accused of releasing the drug without adequate research.
Actos Lawsuit Notices
Geschrieben von tmargolin 110 Tage vor (http://www.actos-attorneys.com)Wer hat für diese News gestimmt
Tipps und Informationen aus dem Web, von Nutzern eingestellt und bewertet
Kommentare